Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

121 ARTÍCULOS , VIENDO DEL 1 AL 15

Objective and Subjective Cognitive Problems among Caregivers and Matched Non-caregivers

Vitaliano PP, Ustundag O, Borson S.

Gerontologist. 2017 Aug 1;57(4):637-647. doi: 10.1093/geront/gnv690.

Exportation and Validation of Latent Constructs for Dementia Case Finding in a Mexican American Population-based Cohort

Royall DR, Palmer RF, Markides KS.

J Gerontol B Psychol Sci Soc Sci. 2017 Oct 1;72(6):947-955. doi: 10.1093/geronb/gbw004.

Differences in diagnostic process, treatment and social Support for Alzheimer's dementia between primary and specialist care: resultss from the Swedish Dementia Registry

Garcia-Ptacek S, Modéer IN, Kåreholt I, Fereshtehnejad SM, Farahmand B, Religa D, Eriksdotter M.

Age Ageing. 2017 Mar 1;46(2):314-319. doi: 10.1093/ageing/afw189.

Effectiveness of a Standardized and Specific Follow-Up in Memory Centers in Patients with Alzheimer's Disease

Rouch L, Cestac P, Cool C, Helmer C, Dartigues JF, Berr C, Rouaud O, Vellas B, Andrieu S; REAL-FR Study Group and the 3C Study Group.

Curr Alzheimer Res. 2017;14(3):255-267. doi: 10.2174/1567205013666161108114850.

Association of rs610932 and rs670139 Polymorphisms in the MS4A Gene Cluster with Alzheimer's Disease: An Updated Meta-analysis

Zhu R, Liu X, He Z.

Curr Alzheimer Res. 2017;14(3):335-344. doi: 10.2174/1567205013666161108110828.

A Comparison of Sex Differences in Psychotropic Medication Use in Older People with Alzheimer's Disease in the US and Finland

Moga DC, Taipale H, Tolppanen AM, Tanskanen A, Tiihonen J, Hartikainen S, Wu Q, Jicha GA, Gnjidic D.

Drugs Aging. 2017 Jan;34(1):55-65. doi: 10.1007/s40266-016-0419-5.

Sample Size Estimation for Alzheimer's Disease Trials from Japanese ADNI Serial Magnetic Resonance Imaging

Fujishima M, Kawaguchi A, Maikusa N, Kuwano R, Iwatsubo T, Matsuda H; Japanese Alzheimer’s Disease Neuroimaging Initiative (ADNI); Japanese Alzheimer’s Disease Neuroimaging Initiative (J-ADNI).

J Alzheimers Dis. 2017;56(1):75-88. doi: 10.3233/JAD-160621.

[Organizational features influencing health worker's fulfillment in an Alzheimer center and in a nursing home]

Ghiglia S, Garrino L, Gargano A, Raspo S, Pira E, Dimonte V.

G Ital Med Lav Ergon. 2017 Jan;38(4):275-283.

Meta-Prediction of the Effect of Methylenetetrahydrofolate Reductase Polymorphisms and Air Pollution on Alzheimer's Disease Risk

Wu SM, Chen ZF, Young L, Shiao SP.

Int J Environ Res Public Health. 2017 Jan 11;14(1):63. doi: 10.3390/ijerph14010063.

Comprehensive Screening for Disease Risk Variants in Early-Onset Alzheimer's Disease Genes in African Americans Identifies Novel PSEN Variants

N'Songo A, Carrasquillo MM, Wang X, Nguyen T, Asmann Y, Younkin SG, Allen M, Duara R, Custo MT, Graff-Radford N, Ertekin-Taner N.

J Alzheimers Dis. 2017;56(4):1215-1222. doi: 10.3233/JAD-161185.

Association of Docosahexaenoic Acid Supplementation With Alzheimer Disease Stage in Apolipoprotein E ε4 Carriers: A Review

Yassine HN, Braskie MN, Mack WJ, Castor KJ, Fonteh AN, Schneider LS, Harrington MG, Chui HC.

JAMA Neurol. 2017 Mar 1;74(3):339-347. doi: 10.1001/jamaneurol.2016.4899.

Antipsychotic Use and the Risk of Hip Fracture Among Community-Dwelling Persons With Alzheimer's Disease

Koponen M, Taipale H, Lavikainen P, Tanskanen A, Tiihonen J, Tolppanen AM, Ahonen R, Hartikainen S.

J Clin Psychiatry. 2017 Mar;78(3):e257-e263. doi: 10.4088/JCP.15m10458.

Copper-2 Hypothesis for Causation of the Current Alzheimer's Disease Epidemic Together with Dietary Changes That Enhance the Epidemic

Brewer GJ.

Chem Res Toxicol. 2017 Mar 20;30(3):763-768. doi: 10.1021/acs.chemrestox.6b00373. Epub 2017 Mar 3.

Alcohol and Alzheimer's Disease-Does Alcohol Dependence Contribute to Beta-Amyloid Deposition, Neuroinflammation and Neurodegeneration in Alzheimer's Disease?

Venkataraman A, Kalk N, Sewell G, W Ritchie C, Lingford-Hughes A.

Alcohol Alcohol. 2017 Mar 9;52(2):158. doi: 10.1093/alcalc/agw101.

Discontinuation, Efficacy, and Safety of Cholinesterase Inhibitors for Alzheimer's Disease: a Meta-Analysis and Meta-Regression of 43 Randomized Clinical Trials Enrolling 16 106 Patients

Blanco-Silvente L, Castells X, Saez M, Barceló MA, Garre-Olmo J, Vilalta-Franch J, Capellà D.

Int J Neuropsychopharmacol. 2017 Jul 1;20(7):519-528. doi: 10.1093/ijnp/pyx012.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias